BARDA Shake Up May Prompt Broad Review Of Politicization of Countermeasures Office

Rick Bright is requesting an inspector general investigation into his removal as director of the Biomedical Advanced Research and Development, accusing the Trump administration of favoring politics over science when making COVID-19 funding decisions. 

White House

The recently transferred head of the US federal agency responsible for running key COVID-19 vaccine efforts with the drug industry said Wednesday that his abrupt demotion came after he cautioned against directing federal funding to coronavirus treatments that lacked scientific merit and pushed back against green-lighting the widespread use of two anti-malarial drugs championed by President Donald Trump.

Rick Bright who was removed Tuesday from his post as director of the Biomedical Advanced Research and Development Authority and...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet